Cargando…
Proposed methods for evaluating efforts made by governments to prevent and mitigate corporate influence and conflicts of interest in public health policy
Background: There is evidence that corporations try to delay, weaken, and avoid the adoption of measures that would protect and improve population health. This is particularly true and problematic for health harming industries, such as those producing ultra-processed foods, alcohol, and cigarettes....
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366553/ https://www.ncbi.nlm.nih.gov/pubmed/37496747 http://dx.doi.org/10.12688/hrbopenres.13553.2 |
_version_ | 1785077191470481408 |
---|---|
author | Mialon, Mélissa Bertscher, Adam Bero, Lisa Vandevijvere, Stefanie |
author_facet | Mialon, Mélissa Bertscher, Adam Bero, Lisa Vandevijvere, Stefanie |
author_sort | Mialon, Mélissa |
collection | PubMed |
description | Background: There is evidence that corporations try to delay, weaken, and avoid the adoption of measures that would protect and improve population health. This is particularly true and problematic for health harming industries, such as those producing ultra-processed foods, alcohol, and cigarettes. Financial conflicts of interest (COI) are also problematic in policy-making because they may compromise decision-makers’ loyalty and independent judgment. Public opinion is in favor of preventing and mitigating that influence from corporations and COI on public health policy. A scoping review recently identified twenty-three mechanisms that could be adopted with that purpose and which principally cover: i) transparency and disclosure; ii) identification, monitoring, and education; iii) management; iv) prohibition of interactions with the industry and/or COI. There is, however, limited knowledge on the adoption of such mechanisms by governments. We therefore propose new methods for evaluating that progress at the country level. Methods and expected results: The proposed evaluation comprises five steps: 1) Gathering information about the national context; 2) Gathering evidence on the implementation of mechanisms by national governments; 3) Verification of step 2 by government officials and policy experts and local public health experts; 4) Identification and prioritization of actions in a workshop; 5) Supporting the translation of findings into policy actions. Conclusions: The evaluation of progress made by governments in their implementation of mechanisms for preventing and mitigating the influence of corporations and COI in public health policy could help countries systematize their efforts, benchmark their progress internationally, and give perspective on particular weaknesses, approaches, and investment gaps needed for change. We will implement and validate our methods in Ireland, as a first case-study. |
format | Online Article Text |
id | pubmed-10366553 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-103665532023-07-26 Proposed methods for evaluating efforts made by governments to prevent and mitigate corporate influence and conflicts of interest in public health policy Mialon, Mélissa Bertscher, Adam Bero, Lisa Vandevijvere, Stefanie HRB Open Res Method Article Background: There is evidence that corporations try to delay, weaken, and avoid the adoption of measures that would protect and improve population health. This is particularly true and problematic for health harming industries, such as those producing ultra-processed foods, alcohol, and cigarettes. Financial conflicts of interest (COI) are also problematic in policy-making because they may compromise decision-makers’ loyalty and independent judgment. Public opinion is in favor of preventing and mitigating that influence from corporations and COI on public health policy. A scoping review recently identified twenty-three mechanisms that could be adopted with that purpose and which principally cover: i) transparency and disclosure; ii) identification, monitoring, and education; iii) management; iv) prohibition of interactions with the industry and/or COI. There is, however, limited knowledge on the adoption of such mechanisms by governments. We therefore propose new methods for evaluating that progress at the country level. Methods and expected results: The proposed evaluation comprises five steps: 1) Gathering information about the national context; 2) Gathering evidence on the implementation of mechanisms by national governments; 3) Verification of step 2 by government officials and policy experts and local public health experts; 4) Identification and prioritization of actions in a workshop; 5) Supporting the translation of findings into policy actions. Conclusions: The evaluation of progress made by governments in their implementation of mechanisms for preventing and mitigating the influence of corporations and COI in public health policy could help countries systematize their efforts, benchmark their progress internationally, and give perspective on particular weaknesses, approaches, and investment gaps needed for change. We will implement and validate our methods in Ireland, as a first case-study. F1000 Research Limited 2022-09-06 /pmc/articles/PMC10366553/ /pubmed/37496747 http://dx.doi.org/10.12688/hrbopenres.13553.2 Text en Copyright: © 2022 Mialon M et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Method Article Mialon, Mélissa Bertscher, Adam Bero, Lisa Vandevijvere, Stefanie Proposed methods for evaluating efforts made by governments to prevent and mitigate corporate influence and conflicts of interest in public health policy |
title | Proposed methods for evaluating efforts made by governments to prevent and mitigate corporate influence and conflicts of interest in public health policy |
title_full | Proposed methods for evaluating efforts made by governments to prevent and mitigate corporate influence and conflicts of interest in public health policy |
title_fullStr | Proposed methods for evaluating efforts made by governments to prevent and mitigate corporate influence and conflicts of interest in public health policy |
title_full_unstemmed | Proposed methods for evaluating efforts made by governments to prevent and mitigate corporate influence and conflicts of interest in public health policy |
title_short | Proposed methods for evaluating efforts made by governments to prevent and mitigate corporate influence and conflicts of interest in public health policy |
title_sort | proposed methods for evaluating efforts made by governments to prevent and mitigate corporate influence and conflicts of interest in public health policy |
topic | Method Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366553/ https://www.ncbi.nlm.nih.gov/pubmed/37496747 http://dx.doi.org/10.12688/hrbopenres.13553.2 |
work_keys_str_mv | AT mialonmelissa proposedmethodsforevaluatingeffortsmadebygovernmentstopreventandmitigatecorporateinfluenceandconflictsofinterestinpublichealthpolicy AT bertscheradam proposedmethodsforevaluatingeffortsmadebygovernmentstopreventandmitigatecorporateinfluenceandconflictsofinterestinpublichealthpolicy AT berolisa proposedmethodsforevaluatingeffortsmadebygovernmentstopreventandmitigatecorporateinfluenceandconflictsofinterestinpublichealthpolicy AT vandevijverestefanie proposedmethodsforevaluatingeffortsmadebygovernmentstopreventandmitigatecorporateinfluenceandconflictsofinterestinpublichealthpolicy |